Podiatrists in Narragansett, RI Accepting Medicare

3 Podiatrists found. Showing 1 - 3

Dr. Brooke Keeley, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 360 Kingstown Rd, Suite 106, Narragansett, RI 02882 Phone: 401-782-8787

Karen F. Lamorge, Dpm, Ltd Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 360 Kingstown Rd, Suite 106, Narragansett, RI 02882 Phone: 401-782-8787    Fax: 401-789-2811

Narragansett Foot & Ankle Center, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 360 Kingstown Rd, Suite 106, Narragansett, RI 02882 Phone: 401-782-8787

News Archive

Patient-centered care associated with improved patient outcomes

Providing patient-centered care consistently in clinical practice requires practitioners who are able to recognize that different clinical situations require different approaches and are skilled enough to adapt.

Canadian tourist bitten by a Katipo spider in New Zealand

A Canadian tourist suffered a serious heart inflammation called myocarditis after he was bitten by a poisonous spider when he went swimming nude in New Zealand.

Low vaccination rates across Australia

Vaccination rate figures show that older Australians are well protected against the flu but less so against pneumococcal disease and whooping cough. These figures were revealed by the Australian Institute of Health and Welfare (AIHW) and they show three-quarters of Australians aged 65 years and older had a flu shot in 2009. Just over half (55 per cent) were also vaccinated against pneumococcal disease.

Monoclonal antibody nivolumab improves survival rates of melanoma patients

The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center will be presenting data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.

Body fat not always bad

With the threat of an obesity crisis looming, a study led by UCL researchers reveals today that fat tissue isn't always the enemy. Reporting in the journal Science they show that a molecular signalling pathway in fat tissue is an important mediator in extending lifespan.

Read more Medical News

› Verified 7 days ago